| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |